Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
22 Jun, 2026, 12.25 PM IST
Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
19 Jun, 2026, 02.23 PM IST
Xiaomi India charts post-Anuj Sharma roadmap with South Asia headquarters push and large appliances expansion planThe company reported strong gains in premium smartphones, tablets and TVs, outlined plans to enter large appliances, and announced leadersh...
18 Jun, 2026, 04.30 PM IST
FIFA World Cup 2026 Live Streaming: How to watch every match online free from anywhereHow to watch every FIFA World Cup match online, free streaming options, TV channels, mobile apps, match schedules, and live coverage from a...
17 Jun, 2026, 10.57 AM IST
Stocks in news: Dr Reddy’s, Adani Green, KIMS, JSW Energy, Nestle IndiaMarkets saw a strong rebound on Friday, driven by positive global cues and easing geopolitical tensions. Nifty defended the 23,000 support ...
15 Jun, 2026, 06.01 AM IST
UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
12 Jun, 2026, 08.36 AM IST
Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
10 Jun, 2026, 01.11 PM IST
Xiaomi 17T review: Value smartphone done rightThe Xiaomi 17T strikes a balance between performance and camera capabilities, offering a well-rounded premium smartphone experience. While ...
08 Jun, 2026, 07.05 PM IST
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
01 Jun, 2026, 04.49 PM IST
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
31 May, 2026, 01.34 PM IST
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 crSpecialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with a...
24 May, 2026, 02.41 PM IST
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Quote of the day by Michael Dell: 'Every breakthrough business idea begins with solving a common problem. The bigger the problem, the bigger the...' - insipring lessons on entrepreneurship and how to building successful businesses by Dell Technologies CEO and founderQuote of the day by Michael Dell: Michael Dell, founder of Dell Technologies, believes great business ideas stem from solving everyday prob...
23 May, 2026, 09.11 PM IST
Market will be volatile, look for an alternative solution: 5 large-caps from different sectors with upside potential of up to 30%A fall in crude oil prices can trigger a relief rally, which in fact it did in early trade on Thursday. But there is another reality as wel...
21 May, 2026, 03.07 PM IST
Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
20 May, 2026, 08.06 PM IST
Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
20 May, 2026, 06.28 PM IST